ClinicalTrials.Veeva

Menu

Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock

N

Northern Jiangsu People's Hospital

Status and phase

Completed
Phase 3

Conditions

Septic Shock

Treatments

Drug: Placebo
Drug: Vitamin C,thiamine,hydrocortisone

Study type

Interventional

Funder types

Other

Identifiers

NCT03872011
2019KY-145

Details and patient eligibility

About

The purpose of this study is to determine whether the combination therapy (vitamin C,thiamine and hydrocortisone) is effective in the treatment of septic shock.

Full description

Septic Shock is a leading cause of morbidity and mortality in critically ill patients worldwide.

A potential benefit of vitamin C with thiamine and low-dose hydrocortisone in the treatment of septic shock has recently been described(PMID 27940189) . The patients with septic shock who received this combination of medications weaned off pressors earlier, suffered less organ failure, and had improved mortality. The doses of vitamin C used in this trial are high, yet seemed to be safe and can be considered for use.

In this randomized controlled trial, we aim to evaluate the effect of the combination therapy (vitamin C,thiamine and hydrocortisone) on septic shock.

Enrollment

408 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years old or older
  • Onset of septic shock within 12 hours

Exclusion criteria

  • Systemic corticosteroid therapy within the last 3 months before septic shock
  • High-dose steroid therapy
  • Immunosuppression
  • Pregnant
  • Known glucose-6 phosphate dehydrogenase (G-6PD) deficiency
  • Known hemachromatosis
  • Known allergy to vitamin C, hydrocortisone, or thiamine
  • Anticipated death from a preexisting disease within 90 days after randomization (as determined by the enrolling physician)
  • Refusal of the attending staff or patient family

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

408 participants in 2 patient groups, including a placebo group

Vitamin C,thiamine,hydrocortisone
Experimental group
Description:
The combination of vitamin C, thiamine, hydrocortisone : Vitamin C 2g every 6 hours x 5-days Thiamine 200mg every 12 hours x 5-days Hydrocortisone 200mg as a continuous infusion x 5-days
Treatment:
Drug: Vitamin C,thiamine,hydrocortisone
Placebo
Placebo Comparator group
Description:
Normal Saline Solution (0.9%NaCl) in a volume to match all experimental arm components
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems